Interaction of suppressor of cytokine signalling 3 with cavin-1 links SOCS3 function and cavin-1 stability by Williams, Jamie J.L.. et al.
ARTICLE
Interaction of suppressor of cytokine signalling 3
with cavin-1 links SOCS3 function and cavin-1
stability
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Effective suppression of JAK–STAT signalling by the inducible inhibitor “suppressor of
cytokine signalling 3” (SOCS3) is essential for limiting signalling from cytokine receptors.
Here we show that cavin-1, a component of caveolae, is a functionally signiﬁcant SOCS3-
interacting protein. Biochemical and confocal imaging demonstrate that SOCS3 localisation to
the plasma membrane requires cavin-1. SOCS3 is also critical for cavin-1 stabilisation, such
that deletion of SOCS3 reduces the expression of cavin-1 and caveolin-1 proteins, thereby
reducing caveola abundance in endothelial cells. Moreover, the interaction of cavin-1 and
SOCS3 is essential for SOCS3 function, as loss of cavin-1 enhances cytokine-stimulated
STAT3 phosphorylation and abolishes SOCS3-dependent inhibition of IL-6 signalling by cyclic
AMP. Together, these ﬁndings reveal a new functionally important mechanism linking
SOCS3-mediated inhibition of cytokine signalling to localisation at the plasma membrane via
interaction with and stabilisation of cavin-1.
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Cytokines control many important biological responses,including haematopoiesis, T-cell differentiation andexpansion, and inﬂammatory status1,2. Multiple tempo-
rally distinct inhibitory mechanisms operate to ensure signalling
responses downstream of activated cytokine receptors are tran-
sient in nature. Therefore, sustained pathway activation perpe-
tuates chronic inﬂammatory conditions such as rheumatoid
arthritis and colitis, haematological malignancies such as poly-
cythemia vera, and also solid tumour development3–5.
Several cytokine receptors, including gp130 (the signal trans-
ducing component of the interleukin-6 (IL-6) signalling com-
plex), activate receptor-associated Janus kinases (JAKs) which
then trigger receptor engagement with proteins such as signal
transducer and activators of transcription (STATs), particularly
STAT3. Phosphorylated STATs can then dimerise and translocate
to the nucleus, where they function as transcription factors by
binding to speciﬁc promoter elements and recruiting transcrip-
tional co-activators1,2.
“Suppressors of cytokine signalling” (SOCS) proteins comprise
a family of eight related members (cytokine-inducible SH2-
containing protein (CIS), SOCS1–7) identiﬁed initially by their
role as cytokine-inducible negative feedback inhibitors of signal
propagation from speciﬁc cytokine receptors6. SOCS3 is recruited
to activated cytokine receptors following the formation of a
SOCS3 interaction motif upon phosphorylation of key Tyr resi-
dues by cytokine-activated JAKs. SOCS3 terminates signalling
from gp130 by binding via a central SH2 domain to PTyr759,
allowing it to interact with and inhibit adjacent receptor-bound
JAKs via its kinase inhibitory region (KIR) thereby preventing the
recruitment and tyrosine phosphorylation of STATs7. The C-
terminal SOCS box domain directs SH2 domain-bound inter-
acting proteins for ubiquitylation due to its ability to bind elongin
B and C, Cullin family member Cul5, and RING (Really Inter-
esting New Gene) ﬁnger protein Rbx27. Following SOCS3-
dependent ubiquitylation, targets such as FAK1 can be degraded
either by the proteasome8,9 or, in the case of the granulocyte
colony-stimulating factor receptor (G-CSFR), by trafﬁcking into
lysosomal compartments following internalisation10. However,
despite advances in our molecular understanding of how SOCS3
interacts with cytokine receptors and JAKs, the extent to which
other cellular proteins regulate SOCS3 function is unclear.
Recently, CUE domain-containing 2 (CUEDC2) was identiﬁed as
a novel SOCS3-interacting protein that could enhance its inter-
action with elongin C11. Such observations raise the possibility
that additional protein interactors may be required to maximise
the ability of SOCS3 to regulate signalling.
Cavin-1 (alternatively known as polymerase I and transcript
release factor (PTRF)) is an abundant component of caveolae,
which function as specialised lipid raft microdomains within the
plasma membrane. Caveolae were ﬁrst identiﬁed by electron
microscopy as 50–100 nm ﬂask-shaped plasma membrane inva-
ginations12 and are now known to play critical roles in controlling
endocytosis, sphingolipid metabolism, and compartmentalisation
of signalling pathways13. Cavin-1, which is one of a family of four
related proteins (cavins 1 to 4), is recruited by one or more
“caveolin” proteins (caveolins 1 to 3) to the plasma membrane
during the latter stages of caveola biogenesis, and is thought to be
essential for caveola formation by stabilising caveolin proteins at
the plasma membrane14.
While some studies have demonstrated localisation of cytokine
receptors and JAKs in lipid raft microdomains15–18, little is
known about the impact of caveolin expression/function on
JAK–STAT signalling and no studies have speciﬁcally examined a
role for cavins. In this study, we identify a novel interaction
between SOCS3 and cavin-1. This interaction is not only required
for optimal SOCS3-mediated inhibition of IL-6-mediated
JAK–STAT signalling but also for effective stabilisation of
cavin-1 and hence caveolin-1. Therefore, our ﬁndings deﬁne a
new relationship between SOCS3 and cavin-1 in which each
partner plays previously unappreciated roles in maintaining
effective inhibition of JAK–STAT signalling (cavin-1), cavin-1
expression, and caveola stability (SOCS3).
Results
Cavin-1 as a SOCS3-regulated ubiquitylated protein. As well as
inhibiting cytokine receptor signalling by inhibiting the Tyr
kinase activity of receptor-bound JAKs19, SOCS3 can also control
the stability of SH2 domain-bound proteins as part of an elongin/
cullin/SOCS3 (ECSSOCS3) E3 ubiquitin ligase complex6,7,20.
While several ubiquitinated substrates of SOCS3 are known, the
full spectrum has yet to be identiﬁed. Thus, we pursued an
experimental approach to elaborate on SOCS3 function by
investigating SOCS3-regulated proteins. Since there is no con-
sensus sequence for ubiquitylation, we used a stable isotopic
labelling of amino acids in cell culture (SILAC)/mass spectro-
metry approach to compare ubiquitinomes from wild-type SOCS3
+/+ (WT) and SOCS3−/− murine embryonic ﬁbroblast (MEF) cell
lines expressing equivalent levels of a tandem afﬁnity
puriﬁcation-compatible tagged ubiquitin transgene following
SOCS3 induction (Supplementary Fig. 1). Using this approach,
ubiquitylated proteins regulated by SOCS3 would be predicted to
be enriched in WT but not SOCS3−/− MEFs.
A ubiquitin transgene containing a tandem hexahistidine and
biotin tag (HB-Ub) was used to allow two-step tandem afﬁnity
puriﬁcation of the ubiquitinome via sequential Ni-NTA and
streptavidin afﬁnity chromatography under fully denaturing
conditions necessary to inactivate deubiquitinases and prevent
co-puriﬁcation of non-covalently interacting ubiquitin-binding
proteins21,22. Stable HB-Ub-expressing WT and SOCS3−/− MEFs
were generated via retrovirus-mediated gene transfer and assessed
by immunoblotting for equivalent expression levels of the HB-Ub
transgene. SOCS3 was induced by elevation of intracellular cyclic
adenosine monophosphate (cAMP) levels with forskolin (50 μM),
a direct activator of adenylyl cyclase. To increase the probability
of detecting proteins whose ubiquitylation was SOCS3 dependent,
protein tyrosine phosphatases were inhibited using a combination
of sodium orthovanadate and H2O2 to preserve the PTyr status of
potential substrates and maximise interaction with the SOCS3
SH2 domain23, while the ubiquitinome was preserved using
proteasome inhibitor MG132. Tandem afﬁnity-puriﬁed ubiquiti-
nomes from WT and SOCS3−/− MEFs were then analysed using
an Orbitrap Velos FTMS and data processed using the MaxQuant
computational platform24 (170). Under these conditions, Max-
Quant detected cavin-1 (O54724) with a log2(normalised H L−1)
= 1.37 (5 unique peptides, count ratio of 6). This suggested
that cavin-1 was a ubiquitylated protein speciﬁcally depleted in
SOCS3−/− MEFs.
SOCS3 enhances cavin-1 stability. Our proteomics screen sug-
gested that SOCS3 regulates cavin-1 stability. To examine this, we
compared the ability of increasing levels of SOCS3 to trigger the
proteasomal degradation of co-transfected cavin-1 and FAK1, a
previously characterised substrate of ECSSOCS38,9. Consistent
with previous work, increased SOCS3 expression triggered a
decrease in FAK1 levels that could be rescued by inclusion of
proteasome inhibitor MG132. In contrast, levels of cavin-1 were
not altered even at the highest level of SOCS3 expression and
were not increased by proteasome inhibitor MG132 (Fig. 1a). To
determine whether SOCS3 could regulate levels of endogenous
cavin-1, we assessed the effects of SOCS3 deletion on cavin-1
expression levels in MEFs. Immunoblotting of whole-cell extracts
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revealed that levels of cavin-1 protein were signiﬁcantly reduced
in SOCS3−/− MEFs versus WT cells. This reduction occurred
under conditions in which cavin-1 mRNA levels were sig-
niﬁcantly increased in SOCS3−/− MEFs versus WT cells (Fig. 1b,
c). The decrease in cavin-1 protein was paralleled by a similar
decrease in caveolin-1 expression levels (Fig. 1b), which is con-
sistent with previous studies showing that loss of cavin-1 triggers
reductions in all three caveolin isoforms14. We then measured the
half-lives of cavin-1 protein in WT and SOCS3−/− MEFs by
monitoring time-dependent changes in cavin-1 expression in
whole-cell extracts following inhibition of protein synthesis with
emetine25. For these experiments, cells were also pre-treated with
forskolin (Fsk) to elevate cAMP levels and increase SOCS3
expression in WT MEFs26,27 Direct comparison of cavin-1
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Fig. 1 Cavin-1 stability is enhanced in the presence of SOCS3. a HEK293 cells co-transfected with ﬁxed amounts of either myc-tagged FAK1 or GFP-cavin-1
expression constructs and increasing levels of Flag-SOCS3 were treated with or without proteasome inhibitor MG132 (6 μM) as indicated. Detergent-
soluble whole-cell lysates were analysed by SDS-PAGE and immunoblotting. b Detergent-soluble whole-cell lysates prepared from SOCS3+/+ (+/+) and
SOCS3−/− (−/−) MEFs equalised for protein content were analysed by SDS-PAGE and immunoblotting. c Quantitative real-time PCR of cavin-1 mRNA
levels in WT (SOCS3+/+) and SOCS3−/−MEFs. Data are presented as mean± standard error for N= 3 experiments. d Upper: Protein-equalised soluble cell
extracts from SOCS3+/+ and SOCS3−/−MEFs chased for the indicated times in serum-free medium with protein synthesis inhibitor emetine (100 μM) were
analysed by SDS-PAGE and immunoblotting with the indicated antibodies. Lower: Quantitation of cavin-1 levels in SOCS3+/+ and SOCS3−/− MEFs is also
shown. Results are presented as mean values± standard error for N= 3 experiments. *P< 0.05 vs. corresponding treatment in SOCS3+/+MEFs, ψP< 0.05
vs. t= 0
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Fig. 2 Effect of SOCS3 deletion on caveola abundance in endothelial cells. a Upper: Detergent-soluble whole-cell lysates from WT and SOCS3-null AS-M.5
human angiosarcoma-derived ECs treated with either vehicle or 50 μM Fsk for 5 h were equalised for protein content for SDS-PAGE for immunoblotting
with the indicated antibodies. Lower: Quantitation of cavin-1 and caveolin-1 protein levels in unstimulated AS-M.5 cells is presented as mean± standard
error for N= 3 experiments. *P< 0.05, **P< 0.01 vs. WT cells. b Transmitting electron microscopy (TEM) was performed on WT and SOCS3-null AS-M.5
cells as indicated. Cell surface caveolae (indicated by the arrows) were readily detectable in WT cells (left panel). In contrast, plasma membranes from
SOCS3-null cells were ﬂat and caveolae density was signiﬁcantly reduced compared to WT cells (right panel). Scale bar= 0.5 μm. c Quantitation of caveola
density (number of caveolae per μm of plasma membrane) in WT and SOCS3-null AS-M.5 cells. ***P< 0.0001 vs. WT cells
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stability in WT versus SOCS3−/− MEFs demonstrated that the
absence of SOCS3 signiﬁcantly reduced the half-life from >8 h
(WT MEFs) to 2 h (SOCS3−/− MEFs: Fig. 1d). Thus, in contrast
to the well-deﬁned role of SOCS3 in destabilising target proteins
by targeting them for ubiquitylation and proteasomal degrada-
tion, the presence of SOCS3 stabilised cavin-1.
Effect of SOCS3 deletion on caveola abundance. Our data thus
far suggested that SOCS3 was an important regulator of caveolin-
1 abundance via stabilisation of cavin-1. Homozygous deletion of
the cavin-1 gene in mice results in marked reductions in the
expression of all caveolin isoforms and a lack of detectable
caveolae in multiple cell types, including endothelial cells (ECs) in
which caveolae are especially abundant14.
To examine the impact of SOCS3 on caveola abundance,
clustered regularly interspaced short palindromic repeats
(CRISPR)/Cas9 technology was used to generate SOCS3-null
AS-M.5 human angiosarcoma-derived immortalised ECs28.
Treatment of WT AS-M.5 cells with cAMP-elevating agent Fsk
was able to promote SOCS3 induction similar to that observed in
MEFs and primary EC lines as previously reported26,27 However,
this effect was lost in SOCS3-null AS-M.5 cells, while Nur77, a
well-characterised cAMP-inducible gene product29, was detect-
able in both WT and SOCS3-null AS-M.5 cells following Fsk
treatment (Fig. 2a, Supplementary Fig. 2). Similar to MEFs
(Fig. 1b), SOCS3 deletion signiﬁcantly reduced cavin-1 and
caveolin-1 protein levels in AS-M.5 whole-cell extracts (Fig. 2a),
demonstrating that this effect is independent of the cell system
being investigated.
We then used transmission electron microscopy (TEM) to
assess any consequences of the observed changes in cavin-1 and
caveolin-1 expression on the abundance of cell surface caveolae.
Caveolae were readily detectable in WT AS-M.5 cells as plasma
membrane-localised ﬂask-shaped invaginations ranging from 50
to 100 nm in diameter (Fig. 2b). In contrast, these were barely
detectable in SOCS3-null cells (Fig. 2b, c). Therefore, signiﬁcant
reductions in cavin-1 and caveolin-1 protein levels triggered by
the loss of SOCS3 in endothelial cells are translated into
signiﬁcantly reduced numbers of cell surface caveolae.
Cavin-1 interacts with SOCS3 via a SH2 domain PEST
sequence. To assess whether SOCS3 could directly interact with
cavin-1, co-immunoprecipitation (co-IP) experiments were per-
formed in lysates isolated from transfected HEK293 cells tran-
siently expressing Flag-SOCS3 and myc-cavin-1. These
experiments demonstrated that myc-cavin-1 was present in anti-
Flag antibody immunoprecipitates only when co-expressed with
Flag-SOCS3, indicating the two proteins formed a complex
(Fig. 3a). Similar results were obtained using Flag-cavin-1 and
HA-SOCS3 (Supplementary Fig. 3), indicating that the effect was
independent of the combination of tags used. Analysis of lysates
and unbound samples from the experiments demonstrated that
under conditions in which SOCS3 could be fully precipitated
from lysates, a proportion of cavin-1 remained unbound, sug-
gesting that not all available cavin-1 could interact with SOCS3
under these condition (Supplementary Fig. 4). To assess the
interaction of endogenously expressed SOCS3 and cavin-1, WT
and SOCS3-null AS-M.5 cells were stimulated with Fsk prior to
IP of cavin-1 and analysis by immunoblotting. These experiments
demonstrated that immunoreactive SOCS3 was speciﬁcally enri-
ched in cavin-1 IPs from WT AS-M.5 cells (Fig. 3b), consistent
with the co-IP data from experiments using transfected cells
(Fig. 3a).
To identify the regions within SOCS3 that are important for
SOCS3/cavin-1 interaction, we initially utilised a panel of Flag-
tagged N- and C-terminal SOCS3 truncation mutants30,31 for
their ability to co-IP green ﬂuorescent protein (GFP)-tagged
cavin-132 as compared to WT SOCS3. Interestingly, all of the
truncation mutants tested were able to co-IP GFP-cavin-1 to the
same extent as full-length WT SOCS3 (Fig. 3c), suggesting that a
region within the SH2 domain present in each of the mutants was
necessary for SOCS3 binding to cavin-1. To test this, we
expressed full-length SOCS3 (residues 1–225) and the region of
the SOCS3 SH2 domain (residues 46–142, termed SOCS3 ΔSH2)
required for cavin-1 binding (Fig. 3d) as GFP-tagged fusion
proteins and compared their ability to co-IP myc-tagged cavin-1
in transfected HEK293 cells. As a negative control, we used a GFP
fusion protein containing residues 177–225 of the SOCS box that
we identiﬁed as dispensable for cavin-1 interaction (Fig. 3c).
Similar to WT SOCS3-GFP, SOCS3 ΔSH2-GFP was able to co-IP
myc-tagged cavin-1 above the non-speciﬁc levels observed with
the SOCS3 SOCS box-GFP fusion and cavin-1 alone, albeit not to
the same extent as WT SOCS3-GFP (Fig. 3d, lane 2 versus lane 8).
Therefore, these data showed that residues 46–142 within the
SOCS3 SH2 domain were both necessary and sufﬁcient for
SOCS3 interaction with cavin-1.
As many SOCS3 binding partners, including gp130, CD33 and
FAK1, must be Tyr phosphorylated in order to interact with
SOCS3, we pursued three experimental approaches to examine
whether or not the PTyr-binding pocket within the SOCS3 SH2
domain was required for interaction with cavin-1. First, we
treated transfected HEK293 cells with protein Tyr phosphatase
inhibitor sodium orthovanadate in the presence or absence of
hydrogen peroxide23. These experiments demonstrated that the
isolation of GFP-cavin-1 in anti-Flag (SOCS3) immunoprecipi-
tates was not altered by increases in global Tyr phosphorylation
levels (Fig. 4a), suggesting that cavin-1 formed a complex with
SOCS3 via a mechanism that did not require prior Tyr
phosphorylation. Secondly, we tested R71K-mutated SOCS3, in
which the conserved PTyr binding site within the SOCS3 SH2
domain is disrupted30,31, for its ability to form a complex with
cavin-1. Co-IP assays revealed that a R71K-mutated SOCS3
bound cavin-1 equivalently to WT SOCS3 (Fig. 4b), again
supporting the concept that cavin-1 interacted with the SOCS3
SH2 domain in a manner independent of its capacity to bind Tyr-
phosphorylated ligands. Finally, N-terminally biotinylated pep-
tides encompassing the Tyr759 motif of gp130 in phosphorylated
(PTyr759 peptide) and non-phosphorylated (Tyr759 peptide)
forms were used as bait to test the effect of cavin-1 co-expression
on the ability of SOCS3 to be precipitated in peptide pull-down
assays. As reported by others30, SOCS3 speciﬁcally associated
with the PTyr759 peptide under these conditions. Using a
maximally effective concentration of peptide (100 nM), co-
expression with cavin-1 did not reduce the ability of SOCS3 to
precipitate with PTyr759 peptide (Fig. 4c). Taken together, these
data demonstrated that cavin-1 interacted with the SOCS3 SH2
domain at a location distinct from the well-deﬁned PTyr-binding
pocket.
The region of the SOCS3 SH2 domain identiﬁed in the studies
above consists of two structurally distinct components. Firstly,
residues 46–127 comprise of β-sheet and α-helical regions that
form part of the PTyr-binding pocket common to all SH2
domains. Secondly, residues 128–142 form part of an unstruc-
tured PEST sequence insert that links the SH2 domain helix B
with BG loop and βG strand motifs (residues 166–185)33. PEST
motifs are unstructured hypermobile regions that have roles in
multiple cellular processes by controlling protein–protein inter-
actions and protein turnover34,35. We noted the presence of a
PEST sequence within the classic SH2 domain structure is also
displayed by CIS but none of the other SOCS family proteins33.
Having excluded the PTyr-binding functionality for SH2 domain
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interaction with cavin-1, we next examined whether the PEST
sequence insert was involved. To do this, we utilised a ΔPEST
SOCS3 deletion mutant in which the PEST motif (Pro129-
Arg163) was removed and replaced with (Gly-Ser)x436. ΔPEST
SOCS3 was expressed at comparable levels to WT SOCS3 in
transfected HEK293 cells and, consistent with previously
published work33, replacement of the PEST sequence did not
diminish speciﬁc interaction with PTyr759 peptide as determined
by in vitro peptide pull-down assays (Fig. 5a). In contrast, the
ability of ΔPEST SOCS3 to bind cavin-1 in co-IP experiments
was almost completely lost (Fig. 5b), thus demonstrating that the
SOCS3 SH2 domain PEST insert was speciﬁcally required for
cavin-1 interaction. Additional co-IP experiments using CIS,
which also has a PEST insert in its SH2 domain, revealed that it
was also able to form a complex with cavin-1 in co-transfected
cells (Fig. 5c). Next we sought to determine whether the SOCS3
a
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Fig. 3 A region within the SOCS3 SH2 domain is necessary and sufﬁcient for cavin-1 interaction. a Protein-equalised soluble cell extracts from HEK293 cells
transfected with expression constructs encoding Flag-SOCS3 and myc-tagged cavin-1 as indicated were processed by immunoprecipitation (IP) with anti-
Flag M2-agarose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the samples used in the IP were also
fractionated by SDS-PAGE for immunoblotting in parallel. b Protein-equalised soluble cell extracts from WT and SOCS3-null AS-M.5 cells treated with 50
μM Fsk and 6 μMMG132 for 4 h were processed by IP with anti-cavin-1 antibody prior to SDS-PAGE and immunoblotting with the indicated antibodies. As
loss of SOCS3 in AS-M.5 cells reduces cavin-1 protein levels (a), twice the amount of protein was used as input for SOCS3-null cells to compensate. NS=
non-speciﬁc band. c Upper: Protein-equalised soluble cell extracts from HEK293 cells transfected with expression constructs encoding either Flag-tagged
WT SOCS3 or the indicated truncation mutants and GFP-tagged cavin-1 as indicated were processed by IP with anti-Flag M2-agarose beads prior to SDS-
PAGE and immunoblotting with the indicated antibodies. Whole-cell lysates from the same samples used in the IP were also fractionated by SDS-PAGE for
immunoblotting in parallel. Lower: Schematic of the SOCS3 truncation constructs used, KIR = kinase inhibitory region, ESS = extended SH2 subdomain,
PEST = PEST (ProGluSerThr) motif. d Upper: Protein-equalised soluble cell extracts from HEK293 cells co-transfected with expression constructs encoding
either full-length SOCS3 (WT), a truncated ΔSH2 SOCS3domain (ΔSH2), or SOCS box domain (SB) fused to GFP and myc-tagged cavin-1 as indicated
were processed by IP with anti-GFP antibody and protein G-Sepharose beads prior to SDS-PAGE and immunoblotting with the indicated antibodies. Whole-
cell lysates from the same samples used in the IP were also fractionated by SDS-PAGE and for immunoblotting in parallel. Lower: Schematic of the SOCS3-
GFP fusions used
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PEST sequence was sufﬁcient to confer interaction with cavin-1.
Bioinformatic analysis using ePESTﬁnd (http://emboss.
bioinformatics.nl/cgi-bin/emboss/epestﬁnd) identiﬁed human
Grap2 as a candidate SH2 domain-containing protein that lacked
a detectable PEST sequence. In addition, Grap2 was unable to
form a complex with cavin-1 upon co-expression in transfected
HEK293 cells (Fig. 5d). Therefore, Pro129-Arg163 from SOCS3
was transplanted onto the central Grap2 SH2 domain and the
resulting chimera (Grap2-S3PEST) assessed for its ability to form
a complex with co-expressed cavin-1 in transfected HEK293 cells.
These experiments demonstrated that insertion of SOCS3 PEST
sequence was sufﬁcient to confer an ability to bind cavin-1 on the
resulting Grap2-S3PEST chimera, albeit to a much weaker extent
than WT SOCS3 (Fig. 5d).
Multiple cavin-1 regions required for SOCS3 interaction. To
examine whether SOCS3 interacts directly with cavin-1, peptide
arrays of overlapping 25-mer peptides sequentially shifted by ﬁve
amino acids and spanning the full-length cavin-1 open reading
frame were overlaid with puriﬁed recombinant SOCS3 and
visualised by probing with anti-SOCS3 antibodies (Fig. 6a). Dark
spots represent positive areas of SOCS3 interaction. Using this
approach we found that SOCS3 could interact strongly with two
distinct regions spanning >70 amino acids within the cavin-1
open reading frame: an N-terminal region spanning residues
75–152 and a C-terminal region encompassing residues 200–295.
To validate the importance of these regions in controlling inter-
action with SOCS3 in intact cells, we generated a panel of myc
epitope-tagged N- and C-terminal truncation mutants of cavin-1
(Fig. 6b) and tested their ability to co-IP Flag-SOCS3 upon co-
expression in transfected HEK293 cells. All the truncated cavin-1
mutants expressed comparably to WT cavin-1 except for the C1
construct encoding residues 1–75 (Fig. 6c). These experiments
demonstrated that, compared with WT cavin-1, each of the N-
terminal and C-terminal truncation mutants was compromised in
its capacity to co-IP with SOCS3. In conjunction with data from
the peptide array experiments, our ﬁndings demonstrate that
multiple SOCS3 binding interfaces within cavin-1 were required
for optimal interaction with SOCS3.
Cavin-1 promotes SOCS3 localisation to the plasma mem-
brane. Cavin-1 is required for stabilisation and maturation of
caveolae at the plasma membrane, although it is also present with
caveolin-1 in non-lipid raft fractions37. SOCS3 is thought to be
a
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recruited to activated cytokine receptors at the plasma membrane
following the formation of a SOCS3 interaction motif upon
phosphorylation of key Tyr residues by cytokine-activated
JAKs19. Therefore, to examine a role for cavin-1 in controlling
SOCS3 localisation, we used confocal microscopy to assess the
effect of cavin-1 deletion on the subcellular distribution of a
SOCS3-GFP fusion protein expressed in transfected cells plated at
low density. A transfected SOCS3-GFP construct was used for
these experiments as we failed to speciﬁcally detect endogenous
SOCS3 staining in WT MEFs over and above background
staining in SOCS3−/− MEFs in confocal imaging experiments
using three separate commercially available antibodies. In trans-
fected WT MEFs, two populations of SOCS3-GFP-derived
ﬂuorescence were detectable: a punctate intracellular pool and a
plasma membrane-localised pool (Fig. 7a). Endogenous cavin-1
was localised predominantly at the plasma membrane of the
trailing edge of the cells as described by others38. Merging of the
images revealed co-localisation of SOCS3-GFP and cavin-1 spe-
ciﬁcally at the plasma membrane (Fig. 7a). Analysis of SOCS3-
GFP/cavin-1 staining produced Pearson's correlation coefﬁcient
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values of >0.90 at the plasma membrane, indicative of a high
degree of co-localisation (Fig. 7b). Conversely, in cavin-1−/−
MEFs SOCS3-GFP was undetectable at the plasma membrane
and only present within a punctate intracellular pool (Fig. 7a).
Importantly, transient co-expression of SOCS3-GFP with co-
transfected cavin-1-mCherry into cavin-1−/− MEFs was able to
restore their co-localisation at the plasma membrane (Fig. 7c).
Expression of GFP alone in WT MEFs did not produce any
detectable co-localisation with cavin-1, and its distribution was
similar in both WT and cavin-1−/− MEFs (Supplementary
Fig. 5A, B).
Additionally, subcellular fractionation experiments demon-
strated that cavin-1 was mainly present in membrane and
cytoplasmic fractions. This mirrored the subcellular distribution
of SOCS3 in WT MEFs following induction by Fsk treatment for
5 h. Interestingly, cavin-1 deletion shifted the distribution of
SOCS3 predominantly to the cytoplasm (Fig. 7d). Thus, the
presence of cavin-1 was important for localising endogenous
SOCS3 to the membrane fraction, consistent with our confocal
imaging experiments using SOCS3-GFP (Fig. 7a–c). Subcellular
fractionation experiments also demonstrated that SOCS3 deletion
produced a comparable reduction in caveolin-1 expression at the
membrane as deletion of cavin-1, indicative of an indirect role for
SOCS3 in maintaining caveolin-1 expression via stabilisation of
cavin-1 (Fig. 7d). This change was speciﬁc for caveolin-1 as levels
of the membrane marker ﬂotillin were unaffected by deletion of
either SOCS3 or cavin-1 (Fig. 7d). Therefore, together these data
indicate that cavin-1 co-localised with a plasma membrane pool
a
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of SOCS3 in intact cells and was an important determinant of
SOCS3 localisation to the plasma membrane.
Cavin-1 limits IL-6-stimulated Tyr705 STAT3 phosphoryla-
tion. While some studies have demonstrated localisation of
cytokine receptors and JAKs in lipid raft microdomains15–18,
relatively little is known about the impact of caveolin expression/
function on JAK–STAT signalling and no studies have speciﬁcally
examined a role for cavins. Our data suggested that cavin-1 and
SOCS3 interacted directly and co-localised at the plasma mem-
brane, while SOCS3 was mainly cytosolic in the absence of cavin-
1. To examine any functional impact of cavin-1 on cytokine
signalling, we examined the effects of cavin-1 deletion in MEFs on
IL-6-mediated activation of STAT3, as determined by phos-
phorylation at Tyr705 which is required for STAT3 to form
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transcriptionally active complexes39. While stimulation of both
WT and cavin-1−/− MEFs with a sIL-6Rα/IL-6 trans-signalling
complex triggered a transient increase in STAT3 phosphorylation
on Tyr705, the response was greater and more sustained in cavin-
1−/− MEFs, being detectable at the 60 and 120 min time points in
cavin-1−/− but less pronounced in WT cells (Fig. 8a). Interest-
ingly, Tyr705 phosphorylation was speciﬁcally enhanced as
STAT3 phosphorylation on Ser727 (which is mediated by several
candidate Ser/Thr kinases40) was unaffected by cavin-1 deletion.
Moreover, the increase in IL-6 signalling occurred despite
reduced levels of JAK1 in cavin-1−/− MEFs, although this
reduction did not reach statistical signiﬁcance (Fig. 8a). Other
cytokine receptor complexes that utilise gp130 include those for
leukaemia inhibitory factor (LIF) and oncostatin M (OSM): LIF
signals via gp130/LIF receptor (LIFR) heterodimers, while OSM
signals downstream using either LIFR/gp130 or OSM receptor/
gp130 complexes41. As observed with sIL-6Rα/IL-6, Tyr705
phosphorylation of STAT3 in response to either LIF or OSM was
greater in cavin-1−/− versus WT MEFs at 60 min (Fig. 8b). Taken
together, these data suggested that loss of cavin-1 compromised
one or more inhibitory mechanisms responsible for suppressing
gp130- and JAK-mediated Tyr phosphorylation of STAT3.
Previous studies have demonstrated that depletion or loss of
SOCS3 results in prolonged activation of STAT3 in response to
speciﬁc cytokines42–44, similar to the effect observed upon cavin-1
deletion. We have shown previously that the ability of cAMP to
inhibit IL-6 signalling in vascular ECs, MEFs, and COS cells has
an absolute requirement for Epac1-dependent induction of
SOCS326,27,45. Given the importance of cavin-1 in localising
SOCS3 to the plasma membrane and the sustained phosphoryla-
tion of STAT3 on Tyr705 observed following sIL-6Rα/IL-
6 stimulation of cavin-1−/− MEFs, we examined the impact of
cavin-1 deletion on the inhibitory effect of cAMP which has
previously been shown to be SOCS3 dependent26,45. These
experiments demonstrated that while pre-treatment of WT MEFs
with cAMP-elevating drug Fsk (50 μM) signiﬁcantly inhibited
sIL-6Rα/IL-6-stimulated Tyr705 phosphorylation of STAT3, this
effect was lost in cavin-1−/− MEFs even though Fsk in
combination with sIL-6Rα/IL-6 produced equivalent levels of
SOCS3 in WT and cavin-1−/− MEFs (Fig. 8c). These results also
did not reﬂect a non-speciﬁc reduction in cAMP responsiveness
following loss of cavin-1 as Fsk could trigger the accumulation of
cAMP target gene Nur77 equivalently in both WT and cavin-1−/−
MEFs (Supplementary Fig. 6). Therefore, the presence of cavin-1
was necessary for SOCS3-mediated inhibition of IL-6 signalling
by cAMP.
Discussion
The importance of SOCS3 in limiting downstream signalling
from cytokine receptor complexes that utilise gp130, as well as the
leptin receptor ObRb and the G-CSFR, is well established6,7
However, relatively little is known about how SOCS3 interaction
with other intracellular proteins can impact on its ability to
inhibit signalling. As part of a study to identify SOCS3-regulated
substrates, we performed “stable isotopic labelling of amino acids
in cell culture” (SILAC) analysis of ubiquitinome proﬁles in WT
and SOCS3−/− MEFs stably expressing a tandem afﬁnity pur-
iﬁcation (TAP)-tagged ubiquitin transgene46. Using this
approach, the caveola scaffolding protein cavin-1 was identiﬁed as
a ubiquitinated protein whose levels were stabilised in WT cells.
We have demonstrated that cavin-1 can interact with SOCS3 and
that the absence of SOCS3 results in increased turnover of cavin-1
and a parallel reduction in cellular levels of caveolin-1 and cell
surface caveloae. We have also demonstrated that cavin-1 is
important for effective SOCS3-mediated suppression of
JAK–STAT signalling in response to sIL-6Rα/IL-6 trans-signal-
ling complexes.
The importance of caveolae and other lipid raft microdomains
for maintaining signalling from the plasma membrane has been
demonstrated for a variety of systems, including endothelial nitric
oxide synthase and Src47,48. In comparison, relatively little
information is available on how they regulate JAK–STAT path-
way activation. Localisation of JAK–STAT signalling components,
including gp130, receptors for growth hormone, ciliary neuro-
trophic factor and LIF, and JAK2 to lipid rafts has been deter-
mined by biochemical fractionation of cell extracts15–18,49–52.
However, the functional consequences appear to be context
dependent, such that raft disruption by treatment with
cholesterol-depleting agents like β-cyclodextrin or homozygous
deletion of caveolin-1 can either inhibit15,16,49 or enhance52,53
downstream signalling. Thus, Lisanti and colleagues52 have
examined the effects of manipulating caveolin-1, and demon-
strated that caveolin-1 can suppress prolactin receptor-mediated
JAK2-dependent phosphorylation and activation of STAT5a in
murine mammary epithelial cells in vitro, consistent with
observations that caveolin-1 deletion in vivo enhances prolactin
receptor signalling53. The mechanism proposed was via a direct
interaction between caveolin-1 and JAK2, although no evidence
of a direct effect of caveolin-1 on JAK2 Tyr kinase activity was
presented52. Other studies have speciﬁcally examined the
importance of caveolae for gp130 function, demonstrating that a
signiﬁcant proportion of cellular gp130 resides in detergent-
resistant lipid rafts and can co-IP with caveolin-1. In addition,
cholesterol depletion with β-cyclodextrin has been shown to
trigger the re-distribution of gp130 to non-raft factions and
attenuate the ability of IL-6 to stimulate STAT3 phosphorylation
on Tyr70516. In contrast, others have found that both gp130 and
STAT3 are localised to lipid rafts15 and demonstrated an inverse
relationship between caveolin-1 expression and STAT3 activa-
tion54. Therefore, while a weak association between membrane
microdomains and JAK–STAT signalling modules has been
made, the molecular mechanisms responsible for this interaction
remain unclear.
Our data would suggest a novel route through which caveola
accessory protein cavin-1 can modulate cytokine receptor sig-
nalling via interaction with the inhibitory regulator SOCS3. While
SOCS3 expression is induced in response to many stimuli, con-
ditional gene targeting strategies have revealed that sensitivity to
SOCS3 is restricted to a panel of plasma membrane-localised
cytokine receptors6,7,41. Consistent with another study38, we
found that while cavin-1 was localised to the plasma membrane
in WT MEFs, it was not distributed uniformly, instead localising
to the trailing edge of migrating cells. Importantly, a signiﬁcant
proportion of SOCS3-GFP co-localised to the same plasma
membrane compartment in WT but not cavin-1−/− MEFs.
Together with data showing that cavin-1 could co-IP with SOCS3
and that puriﬁed SOCS3 could interact with multiple cavin-1-
derived peptides in vitro, we propose that cavin-1 binds SOCS3
directly and that this contributes to efﬁcient SOCS3 recruitment
to the plasma membrane where it can effectively bind and inhibit
cytokine receptors such as gp130. A key aspect of this model
(Fig. 9) is that SOCS3 can still bind Tyr phosphorylated peptide
in vitro in the presence of cavin-1. Interestingly, the SOCS3 SH2
domain appeared to fulﬁl both PTyr and cavin-1 binding func-
tions as cavin-1 interaction required the PEST motif present
within the SOCS3 SH2 domain, which we and others have shown
to be dispensable for PTyr binding33,36. In some respects, this is
similar to the recently described interaction between SOCS3 and
CUEDC2, which also binds the SH2 domain and enhances
SOCS3-mediated inhibition of JAK1–STAT3 activation by IL-611.
Since CUEDC2 potentiates SOCS3 function it would be
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anticipated that, like cavin-1, its interaction with the SH2 domain
must be independent of PTyr binding, suggesting it may also
involve the PEST sequence. However, in contrast to cavin-1,
CUEDC2 localises to the cytoplasm and nucleus55. Nevertheless,
our observations and those of Zhang et al.11 raise the possibility
that multiple proteins may bind within the SOCS3 SH2 domain
to facilitate localisation with Tyr phosphorylated binding partners
in distinct subcellular compartments. In this regard, it should be
noted that confocal imaging and subcellular fraction experiments
detected SOCS3 in the cytoplasm as well as the plasma mem-
brane, and that cavin-1 deletion resulted in the speciﬁc loss of the
plasma membrane pool.
To date, we are only aware of one other study which has
examined the impact of the PEST sequence on SOCS3 function36.
However, these experiments were performed in HEK293 cells co-
transfected to express a STAT3-responsive reporter gene and
increasing amounts of either WT or ΔPEST SOCS3. The authors
noted that at maximal levels of WT and ΔPEST SOCS3 expres-
sion, both constructs abolished LIF-stimulated activation of
STAT3. However, upon normalising SOCS3 function with the
expression levels of WT and ΔPEST SOCS3, they also noted that
at submaximal expression levels the functionality of ΔPEST
SOCS3 was less than that of WT SOCS3. Thus, they concluded
that WT SOCS3 is slightly more efﬁcient at inhibiting STAT3
activation36. Others have shown that low expression levels of
SOCS3 inhibit signalling via interaction with g130 followed by
inhibition of JAK activity, whereas overexpression SOCS3 can
inhibit gp130 signalling independently of interaction with the
SOCS3 binding site and works instead via direct inhibition of
JAK119,56 These data would also suggest that any functional
deﬁcits in ΔPEST SOCS3 in localising to gp130 would be over-
come by its overexpression. In contrast, our functional experi-
ments examining signalling from endogenous proteins suggest an
important aspect of SOCS3 PEST motif function is an interaction
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with cavin-1 that is critical for effective regulation of JAK–STAT
signalling. The effects on signalling of reconstituting cavin-1−/−
MEFs with mutated cavin-1 that fails to interact with SOCS3 but
retains the ability to stabilise caveolin-1 would be very informa-
tive in dissecting whether cavin-1 is essential for SOCS3 function
or simply enhances it through facilitating recruitment to the
plasma membrane. It would also be important to assess any
functional consequences of SOCS3 on gp130 ubiquitylation57 and
receptor trafﬁcking10 in order to fully assess the impact of cavin-1
on SOCS3 function.
While this adds an extra layer of regulation for SOCS3, our
study has also identiﬁed a previously unknown mechanism by
which SOCS3 can regulate cavin-1 function by enhancing its
stability and, as a consequence, maintaining expression levels of
caveolin-1 and cell surface caveolae. Similar observations have
recently been reported for Eps15 homology domain-containing
protein 2 (EHD2) which, to our knowledge, is the only other
example of a cavin-1-interacting protein that regulates caveola
stability, although a direct effect on cavin-1 turnover has not been
examined58. More generally, our ﬁndings also raise the possibility
that cavins constitute a new class of SOCS3-interacting proteins.
While the presence of cavin-1 and caveolin-1 is sufﬁcient to
generate caveolae in many cell types59, MEFs also express cavin-2
and cavin-3. Elegant biochemical and biophysical studies have
demonstrated that cavins assemble into oligomeric complexes
both in cells and in vitro60,61. While each of the cavins is
detectable on individual caveolae59, cavin-2 and cavin-3 appear to
form distinct hetero-oligomeric complexes with cavin-1 rather
than with each other60. Thus, it would be anticipated that
SOCS3 should interact with both cavin-1/cavin-2 and cavin-1/
cavin-3 oligomers and therefore distribute itself uniformly around
caveolar bulbs similarly to cavin-161. As the SOCS3 PEST
sequence was necessary for cavin-1 interaction, it would also be
informative to assess what extent this property is shared among
similar sequences present in other SOCS family members. Ana-
lysis of the SOCS family revealed that CIS, which like SOCS3 can
also interact with cavin-1, contains a PEST motif located in its
SH2 domain, while SOCS1, SOCS5, and SOCS7 each have one or
more PEST sequences located within their N-terminal domains.
In contrast, no PEST motifs are found in SOCS2, SOCS4, and
SOCS6. Given the distinct roles of different SOCS family mem-
bers in regulating signalling62, the functional signiﬁcance of the
identiﬁed PEST motifs and their roles in determining the
localisation of individual SOCS proteins via distinct protein
interactions warrant further investigation.
Finally, our ﬁndings may have implications in the context of
how cavin-1 and SOCS3 dysfunction can trigger disease. Several
inactivating frameshift mutations within exon 2 of the cavin-1
gene that result in the production of altered cavin-1 proteins have
been identiﬁed in patients with general lipodystrophy, muscular
dystrophy, and insulin resistance63–66. In each case, a lack of
functional cavin-1 is associated with the downregulation and/or
mislocalisation of all three caveolin subtypes in skeletal muscle
and an absence of cell surface caveolae in patient-derived ﬁbro-
blasts64 and skeletal muscle63. As multiple regions within cavin-1
are required for optimal binding of SOCS3, the mutated cavin-1
proteins identiﬁed in patients with congenital generalised lipo-
dystrophy would be predicted to be compromised in their ability
to interact with SOCS3, thereby resulting in enhanced IL-6
responses. In this regard, cardiac-speciﬁc homozygous deletion of
murine SOCS3 results in contractile dysfunction and the occur-
rence of a variety of ventricular arrhythmias67, the latter of which
is also observed in patients with inactivating cavin-1 mutations64.
Finally, a F136L germline SOCS3 mutation found in a subset of
polycythemia vera patients has been shown to display an
impaired capacity to inhibit erythropoietin receptor-JAK2 sig-
nalling68. As F136 is located within the PEST insert we have
identiﬁed as critical for cavin-1 interaction, this mutation may
alter cavin-1 binding to SOCS3 to block its inhibitory effects on
JAK–STAT signalling. Based on our ﬁndings, future studies will
therefore need to examine how cavin-1 and/or SOCS3 mutations
identiﬁed in patients interact to trigger defective regulation of
signalling in these pathologies.
Methods
Cell culture and transfection. HEK293 cells were obtained from the European
Collection of Authenticated Cell Cultures (ECACC) through Sigma. Immortalised
SOCS3−/− and cavin-1−/− MEFs and the corresponding WT cell lines have been
described previously59,69. HEK293 cells and MEFs were maintained in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with 10% (v/v) foetal bovine
serum (FBS), 1 mM L-glutamine, 100 Uml−1 penicillin and 100 μM streptomycin.
AS-M.5 human angiosarcoma-derived ECs generously provided by Dr Vera
Krump-Konvalinkova and Professor Charles Kirkpatrick (Johannes Gutenberg
University of Mainz, Germany)28 were cultured in endothelial growth medium-2
supplemented with 2% (w/v) FBS, hydrocortisone, ascorbate, and recombinant
growth factors as recommended by the supplier (Lonza). HEK293 cells at 80%
conﬂuence on poly-D-lysine-coated dishes were transfected with 2–8 μg of com-
plementary DNA (cDNA) per 100 mm dish using PolyFect transfection reagent
(Qiagen) as per THE manufacturer’s instructions.
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For SILAC experiments, MEFs were grown in either heavy SILAC DMEM
(13C6-arginine, 13C6-lysine; R6K6) or control SILAC DMEM (12C6-arginine, 12C6-
lysine; R0K0) (Dundee Cell Products, UK) supplemented with 10% (v/v) dialysed
calf serum, 100 Uml−1 penicillin, 100 μM streptomycin, 4 μg ml−1 puromycin, 200
mg l−1 L-proline and 1 μM D-biotin. Arginine can be metabolised from 13C6-
arginine to an isotope of the non-essential amino acid 13C5-proline via the arginase
pathway thus complicating data analysis70. As such, media were supplemented
with L-proline (200 mg l−1) to prevent arginine conversion. Furthermore, as
overexpression of the HB-Ub-tag reduces the availability of cellular D-biotin21,
growth medium was supplemented with D-biotin (1 μM) to prevent saturation of
in vivo biotinylation by excessive HB-Ub-tag expression. Plat-E retroviral
packaging cells were maintained in DMEM supplemented with 10% (v/v) FBS,
100Uml−1 penicillin, 100 μM streptomycin, 1 μg ml−1 puromycin, 10 μg ml−1
blasticidin, and 1 mM glutamine.
Constructs. Murine Grap2 (cat no. MR204666) and murine CIS (cat no.
MR203328) in pCMV6-Entry were from Origene. Human SOCS3 CRISPR/Cas9
knockout (KO) and human SOCS3 HDR plasmids (cat. no. sc-400455) were from
Santa Cruz Biotechnology. Expression constructs for Flag-tagged WT murine
SOCS3 (hereafter termed pcDNA3/Flag-SOCS3), the truncation mutants ΔN20,
ΔN36, ΔC40, and ΔC84, R71K-mutated SOCS3, and the ΔPEST mutant SOCS3
(generously provided by Dr Jeff Babon, Walter and Eliza Hall Institute of Medical
Research, Australia) have all been described previously30,31,33,71. N-terminally
GFP-tagged murine cavin-1 has been described previously32 while a cavin-1-
mCherry expression construct was generously provided by Dr Ben Nichols (MRC
Laboratory of Molecular Biology, Cambridge, UK).
Full-length murine WT SOCS3, ΔSH2 SOCS3 (amino acids 46–142), and SOCS
box domain-only (amino acids 177–225) GFP fusion proteins were generated by
PCR ampliﬁcation and sub-cloning in-frame with the GFP open reading frame in
pEGFP-N1 (Clontech). The following primers were used to generate PCR products
using pcDNA3/Flag-SOCS3 as the template prior to digestion with the indicated
restriction enzymes for sub-cloning:-
Forward primers: WT (GAA GAA GAA TTC GCC ACC ATG GTC ACC CAC
AGC AAG), SOCS box only (GAA GAA GAA TTC GCC ACC ATG GTA CTG
AGC CGA CCT CTC), SH2 domain only (GAA GAA GAA TTC GCC ACC ATG
TTC TAC TGG AGC GCC GTG). EcoRI sites for sub-cloning underlined,
initiating Met codon in italics. Reverse primers: WT and SOCS box only (TT CTC
GGG ATC CGC AAG TGG AGC ATC ATA CTG ATC CAG G). ΔSH2 SOCS3
(TTC TCG GGA TCC GCT TCC GTG GGT GGC AAA G). BamHI sites for sub-
cloning underlined.
Myc-tagged WT murine cavin-1 and the truncation mutants N1 (amino acids
74–392), N2 (amino acids 168–392), N3 (amino acids 193–392), N4 (amino acids
250–392), C1 (amino acids 1–76), C2 (amino acids 1–167), C3 (amino acids
1–192), and C4 (amino acids 1–249) were generated by PCR ampliﬁcation and sub-
cloning in-frame with the C-terminal myc epitope (EQKLISEEDL) in pcDNA3.1/
mycHis A(-) (Invitrogen). The following primers were used to generate PCR
products using pEGFP-C1/cavin-1 as the template prior to digestion with the
indicated restriction enzymes and sub-cloning:-
Forward primers: WT, C1, C3, C3 and C4 constructs (GGA GAA CCT CTA
GAC GCC ACC ATG GAG GAT GTC ACG CTC), N1 (GGA GAA CCT CTA
GAC GCC ACC ATG CAA GCC CAG CTG GAG), N2 (GGA GAA CCT CTA
GAC GCC ACC ATG CTG AGC GTC AGC AAG TCG), N3 (GGA GAA CCT
CTA GAC GCC ACC ATG CGG CCC GAG GAT GAC ACC), N4 (GGA GAA
CCT CTA GAC GCC ACC ATG ACG CGT GAG AAC CTG GAG). XbaI sites for
sub-cloning underlined, initiating Met codon in italics. Reverse primers: C1 (TTC
TCG GAT CCA CTG GGC TTG GGT CAG CTG), C2 (TTC TCG GAT CCA TTT
GGC CGG CAG CTT GAC), C3 (TTC TCG GAT CCA CTC GCC CTC GCC
CAG CTC), C4 (TTC TCG GAT CCA GCG CAC CTT GGT CTT CTC). WT, N1,
N2, N3, and N4 constructs (TTC TCG GAT CCA GTC GCT GTC GCT CTT
GTC). BamHI sites for sub-cloning underlined.
A mutated Grap2(SOCS3-PEST) in which residues 129–163 encompassing the
SOCS3 PEST sequence were inserted between amino acids 149–150 within the
Grap2 ORF in pCMV6-Entry was synthesised by GeneArtTM. All constructs were
veriﬁed by sequencing to ensure the absence of additional unanticipated mutations.
Retroviral delivery of a His6+biotin Ub (HB-Ub) transgene. Using Lipofecta-
mine2000 (Invitrogen), Plat-E retroviral packaging cells in 10 cm dishes at
approximately 80% conﬂuence were transfected with a HB-Ub-expressing plasmid
kindly donated by Professor Peter Kaiser (University of California at Irvine, USA)
22. Following incubation in media without antibiotic selection, retrovirus-
containing media were collected following two sequential incubation periods, one
of 24 h at 37 °C and a second of 24 h at 32 °C.
Retroviral-mediated generation of cell lines. MEFs in 10 cm dishes at
approximately 40% conﬂuence were transduced with 2 ml of retrovirus containing
media in a ﬁnal volume of 4 ml DMEM supplemented with 10% (v/v) FBS, 1 mM
glutamine, and 10 μg ml−1 polybrene. After 12 h, the media were replaced with
DMEM supplemented with 10% (v/v) FBS, 1 mM L-glutamine and 100Uml−1
penicillin, 100 μM streptomycin and 1 μg ml−1 puromycin to select for positive
clones. Following dilution and re-plating, positive clones were expanded and HB-
Ub-expressing clones identiﬁed by immunoblotting whole-cell extracts with a
polyHis antibody.
Tandem afﬁnity puriﬁcation. SOCS3+/+ and SOCS3−/− MEFs were harvested in
lysis buffer (8M urea, 300 mM NaCl, 50 mM NaH2PO4, 0.5% (v/v) NP-40, pH 8.0)
supplemented with 1 mM phenylmethylsulfonyl ﬂuoride (PMSF). Following
sonication (3 × 10 s pulses, with a 10 s rest phase, at 40% amplitude), supernatants
were isolated by centrifugation at 21,000×g for 30 min at room temperature (RT)
and equalised for protein content. Lysates from SOCS3+/+ and SOCS3−/− MEFs
were mixed in a 1:1 ratio before incubation with 30 μl of 50% (v/v) Ni2+-NTA-
Sepharose beads per milligram of protein and rotated overnight at RT. Beads were
isolated by centrifugation at 100×g for 1 min and then washed sequentially, once
with 20 bead volumes of buffer A (8M urea, 300 mM NaCl, 50 mM NaH2PO4,
0.5% (v/v) NP-40, pH 8.0) supplemented with 1 mM PMSF and 10 mM imidazole
and twice with 20 bead volumes of buffer B (8 M urea, 300 mM NaCl, 50 mM
NaH2PO4, 0.5% (v/v) NP-40, pH 6.3) supplemented with 10 mM imidazole and 1
mM PMSF. Beads were isolated by centrifugation at 100×g for 1 min and bound
proteins eluted twice with 5 bead volumes of elution buffer (8 M urea, 200 mM
NaCl, 50 mM NaH2PO4, 2% (w/v) SDS, 10 mM EDTA,100 mM Tris, 500 mM
imidazole, pH 8.0) supplemented with 1 mM PMSF.
Eluate from the Ni afﬁnity chromatography step was directly added to 10 μl of
50% (v/v) streptavidin-Sepharose beads per milligram of initial protein lysate and
rotated overnight at RT. Beads isolated by centrifugation at 100×g for 1 min at RT
were washed sequentially, twice with 25 bead volumes of buffer C (8 M urea, 200
mM NaCl, 2% (w/v) SDS, 100 mM Tris, pH 8.0) and twice with 25 bead volumes of
buffer D (8 M urea, 1.2 M NaCl, 0.2% (w/v) SDS, 100 mM Tris, 10% (v/v) ethanol,
10% (v/v) isopropanol, pH 8.0). Bound proteins were eluted with one bead volume
of aqueous biotin (50 mM) at 95 °C for 5 min. Following isolation by centrifugation
at 100×g for 1 min at RT, eluate was concentrated using Amicon 10K Ultra-2
Centrifugal Filter Devices (Millipore) as per the manufacturer’s instructions.
In-gel trypsin digestion. Sodium dodecyl sulphate–polyacrylamide gel electro-
phoresis (SDS-PAGE)-fractionated TAP eluate was stained with InstantBlue
(Expedion) prior to manual sectioning into several manageable gel slices. Indivi-
dual gel slices were washed sequentially with 500 μl, 100 mM ammonium bicar-
bonate and then 500 μl, 50% (v/v) acetonitrile/ammonium bicarbonate (100 mM)
for 30 min with shaking. The samples were reduced with the addition of 150 μl 100
mM ammonium bicarbonate and 10 μl 45 mM dithiothreitol for 30 min at 60 °C.
Samples were cooled to RT before alkylation using 10 μl 100 mM iodoacetamide in
the dark for 30 min at RT. Gel pieces were then washed in 500 μl 50% (v/v)
acetonitrile/ammonium bicarbonate (100 mM) for 1 h with shaking at RT. Fol-
lowing treatment with 50 μl acetonitrile for 10 min, the solvent was discarded and
the gel pieces dried using a vacuum centrifuge for 1 h. Gel slices were fully rehy-
drated in trypsin suspended in 1 ml 25 mM ammonium bicarbonate and incubated
overnight at 37 °C after which the supernatant was transferred to a fresh 96-well
plate without disturbing the gel pieces. Residual digested protein was extracted by
using 20 μl 5% (v/v) formic acid for 20 min at RT with shaking followed by the
addition of 40 μl acetonitrile for a further 20 min with shaking at RT. Pooled
extracts were dried using a SpeedVac centrifugal evaporator before resuspension in
10 μl dH20 prior to mass spectrometry.
Liquid chromatography and mass spectrometry. Samples were analysed on a
Dionex Ultimate 3000 RSLS Nano ﬂow system (Dionex). The samples (5 μl) were
loaded onto a Dionex 100 μm× 2 cm 5 μm C18 Nano trap column at a ﬂow rate of
5 μl min−1 by the Ultimate 3000 RS autosampler (Dionex). The composition of the
loading solution was 0.1% formic acid and acetonitrile (98:2). Once loaded onto the
column, the sample was then washed off into an Acclaim PepMap 75 μm× 15 cm,
2 μm 100 Å C18 Nano column at a ﬂow rate of 0.3 μmmin−1. The trap and nano
ﬂow column were maintained at 35 °C in an UltiMate 3000 Rapid Separation LC
system (Thermo Fisher). The samples were eluted with a gradient of solvent A:
0.1% formic acid (solvent A) versus acetonitrile (solvent B) starting at 1% B rising
to 15% then to 45% B over 50 and then 90 min. The column was washed using 90%
B before being equilibrated prior to the next sample being loaded.
Column eluate was directed to a Proxeon Nano spray electrospray ionisation
(ESI) source (Thermo Fisher) operating in positive ion mode and then into an
Orbitrap Velos FTMS. The ionisation voltage was 2.5 kV and the capillary
temperature was 230 °C. The mass spectrometer was operated in tandem mass
spectrometry (MS/MS) mode scanning from 300 to 2000 amu. The top 20 multiply
charged ions were selected from each full scan for MS/MS analysis, the
fragmentation method was CID at 35% collision energy. The ions were selected for
MS2 using a data-dependent method with a repeat count of 1 s and repeat and
exclusion time of 15 s. Precursor ions with a charge state of 1 were rejected. The
resolution of ions in the ﬁrst stage (MS1) was 60,000 and 7500 for the second
stage (CID MS2). Data were acquired using Xcalibur v.2.1 (Thermo Fisher).
Analysis of LC-MS/MS. Post-LC-MS/MS analysis was performed using Max-
Quant v.1.1.1.3672 and searched with Andromeda search engine73 against the IPI
mouse.v3.80 Fasta formatted database (release February 2011). Phosphorylation (S,
T, Y), ubiquitination (GlyGly), and oxidation (Met) were set as variable
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modiﬁcations, whereas carbamidomethylation (Cys) was set as ﬁxed modiﬁcation.
The peptides used for protein quantiﬁcation were set to unique and razor and
minimum ratio count set to 1. Requantify was set to “TRUE” for deep searching of
paired SILAC peaks. “Labelled amino acid ﬁltering” was set to “FALSE” to improve
analysis using R6K6 SILAC labelling. All other options were set to default.
CRISPR/Cas9 generation of SOCS3-null AS-M.5 EC lines. Using SuperFect
transfection reagent (Qiagen), AS-M.5 cells in 6 cm dishes at approximately 80%
conﬂuence were co-transfected with human SOCS3 CRISPR/Cas9 KO and human
SOCS3 HDR plasmids. Following dilution and re-plating, positive clones were
isolated by selection in medium supplemented with puromycin (2 μg ml−1).
SOCS3-null clones were identiﬁed by immunoblotting whole-cell extracts with
SOCS3 antibody following cellular treatment with Fsk (50 μM, 5 h) to induce
SOCS3 gene expression26,45.
Antibodies. The following antibodies were obtained from the indicated suppliers:
anti-Flag M2 antibody (Sigma F3165, 1 in 1000), anti-HA HA-7 antibody (Sigma
H9658, 1 in 1000), PTRF/cavin-1 (Abcam ab48824, 1 in 1000), caveolin-1 (BD
Biosciences 610059, 1 in 1000) and anti-phosphotyrosine monoclonal antibody
4G10 (Millipore 05–321, 1 in 1000), GAPDH (Abcam, ab8245, 1 in 20,000), anti-
myc 9E10 (ascites generated by ProSci, 1 in 2000), anti-α-tubulin 12G10 (DSHB
12G10, 1 in 10,000), SOCS3 (M20; Santa Cruz sc-7009, 1 in 500), STAT3
(EPR787Y: Abcam ab68153, 1 in 1000), phospho-STAT3 (Tyr705) (3E2: Cell
Signaling 9138L, 1 in 1000), phospho-STAT3 (Ser727) (6E4: Cell Signaling 9136, 1
in 1000), JAK1 (BD Transduction Laboratories 610232, 1 in 1000), JAK2 (D2E12:
Cell Signaling 3230, 1 in 1000), and ﬂotillin-1 (BD Transduction Laboratories
610821, 1 in 500). Sheep polyclonal anti-GFP serum was generously provided by
Professor Graeme Milligan (University of Glasgow, UK) and was used in a 1 in
2000 dilution.
Immunoblotting. Cell lysates were prepared as described previously74. Cells were
washed twice with ice-cold phosphate-buffered saline (PBS) and lysed by scraping
into lysis buffer (50 mM HEPES pH 7.4, 150 mM sodium chloride, 1% (v/v) Triton
X-100, 0.5% (v/v) sodium deoxycholate, 0.1% (w/v) SDS, 10 mM sodium ﬂuoride,
5 mM EDTA, 10 mM sodium phosphate, 0.1 mM PMSF, 10 μg ml−1 benzamidine,
10 μg ml−1 soybean trypsin inhibitor, 2% (w/v) EDTA-free complete protease
inhibitor cocktail (Sigma)). After 30 min on ice, lysates were vortexed and cleared
by centrifugation. Equivalent amounts of protein, as determined by bicinchoninic
acid protein assay, were resolved by SDS-PAGE, transferred to a nitrocellulose
membrane, and analysed by immunoblotting as previously described26,74,75.
Uncropped immunoblots used to generate Figs. 1b and 5b are shown in Supple-
mentary Figure 7.
RNA analysis. Total RNA extraction from MEFs grown in 60 mm dishes was
carried out using a miRNeasy Mini Kit (Qiagen) according to the manufacturer’s
instructions. The cDNA was generated from 1 μg total RNA using 200 U Super-
Script™ II Reverse Transcriptase (Invitrogen) following the manufacturer’s
instructions with 100 ng random hexamers, 2.5 mM of each dNTP and 40 U
RNaseOUT (Invitrogen) in a ﬁnal volume of 20 μl. Real-time quantitative PCRs
were performed on a MX3000 system (Stratagene) using Power SYBR® Green PCR
Master Mix (Applied Biosystems) in a ﬁnal volume of 10 μl containing 1 μl cDNA,
0.5 mM of each primer, and 1x Power SYBR® Green PCR Master Mix. The murine
cavin-1 primers used were GCAAGGTCAGCGTCAAC (forward primer) and
CCGGCAGCTTGACTTCA (reverse primer). GAPDH primers used for normal-
isation were GGCTGGCATTGCTCTCAA (forward primer) and
GCTGTAGCCGTATTCATTGTC (reverse primer). Primers were purchased from
Dharmacon.
Co-immunoprecipitation and peptide pull-down assays. For co-IP assays, either
transfected cells or WT and SOCS3-null AS-M.5 cells were harvested in ice-cold
PBS, pelleted by centrifugation at 1000×g for 5 min at 4 °C, and lysed in co-IP
buffer (50 mM HEPES, pH 7.4, 120 mM NaCl, 5 mM EDTA, 10% (v/v) glycerol,
1% (v/v) Triton X-100, 5 mM NaF, 1 mM sodium orthovanadate, 10 μg ml−1
benzamidine, 0.1 mM PMSF, 10 μg ml−1 soybean trypsin inhibitor, 2% (w/v)
EDTA-free complete protease inhibitor cocktail). Following solubilisation by
incubation for 1 h at 4 °C with rotation, lysates were centrifuged at 21,000×g for 15
min at 4 °C and the supernatant equalised for protein content and volume. Non-
speciﬁcally binding proteins were removed from soluble fractions by a 1 h pre-
clearing step using 40 μl of 50% (v/v) slurry of protein G-Sepharose 4B FF beads
(Sigma) re-suspended in 100 μl 2% (w/v) IgG-free bovine serum albumin (BSA).
Following sedimentation of protein G-Sepharose beads by brief centrifugation, pre-
cleared lysates were incubated overnight at 4 °C with rotation with either 40 μl
fresh protein G-Sepharose beads pre-equilibrated with 2% (w/v) IgG-free BSA and
anti-cavin-1 antibody or 40 μl pre-conjugated anti-Flag M2-agarose beads (Sigma).
Immune complexes were then isolated by brief centrifugation and washed three
times with 1 ml of co-IP buffer. Following removal of the ﬁnal wash, protein
complexes were eluted for analysis by SDS-PAGE by the addition of 40 μl of
electrophoresis sample buffer containing 12% (w/v) SDS and incubation for 30 min
at 65 oC followed by a further 5 min at 95 °C.
For peptide pull-down assays, protein-equalised soluble extracts from
transfected HEK293 cells were incubated with 100 nM N-terminally biotinylated
peptides (Severn Biotech, UK) and streptavidin-agarose prior to isolation of
complexes by brief centrifugation and washing as described above. The peptides
used had the following amino acid sequences: Tyr759 (Y), biotin-
TSSTVQYSTVVHSG; and PTyr759 (pY), biotin-TSSTVQpYSTVVHSG). Samples
were then eluted for analysis by SDS-PAGE and immunoblotting as described
above.
Peptide array overlays. Arrays were produced by automatic SPOT synthesis and
synthesised on continuous cellulose membrane supports on Whatman 50 cellulose
membranes using Fmoc-chemistry with the AutoSpot-Robot ASS 222 (Intavis
Bioanalytical Instruments AG) as we have previously described76. Following
blocking of non-speciﬁc protein binding sites by incubation in tris-buffered saline
with Tween-20 (TBST; 50 mM Tris pH 7.5, 150 mM NaCl, 0.1% (v/v) Tween 20)
containing 5% (w/v) BSA, membranes were overlaid with 10 μg ml−1 puriﬁed
recombinant Trx-polyHis-tagged SOCS3 (Sino Biological Inc.) diluted in TBST-5%
(w/v) BSA. After washing in TBST, bound SOCS3 was detected by probing overlays
with anti-SOCS3 antibody followed by IRDye-conjugated secondary antibody prior
to visualisation using a LI-COR Odyssey Sa imaging system. As a negative control,
identical arrays were identically treated in parallel minus recombinant SOCS3.
Subcellular fractionation. Conﬂuent 10 cm dishes of WT, cavin-1−/−, and SOCS3
−/− MEFs were used to prepare subcellular fractions using a Subcellular Protein
Fractionation Kit (Thermo Scientiﬁc) in accordance with the the manufacturer’s
instructions.
Confocal microscopy. For analysis of endogenous cavin-1 and transfected SOCS3-
GFP, WT, and cavin-1−/− MEFs in 10 cm dishes were transiently transfected with
or without SOCS3-GFP expression constructs. The following day, cells were split
onto glass coverslips and left for a further 24 h. Cells were then washed with PBS
and ﬁxed with 3% (w/v) paraformaldehyde (PFA) in PBS for 25 min. After washing
with PBS and quenching residual PFA with 20 mM glycine in PBS, cells were
permeabilised with 0.1% (v/v) Triton X-100 and non-speciﬁc binding sites blocked
by a 30 min of incubation at RT in PBS containing 3% (w/v) BSA and 10% (v/v)
donkey serum. Cells were then incubated with rabbit anti-cavin-1 antibody
(Abcam ab48824, 1 in 100 dilution) for 90 min at RT. Cells were washed with PBS
containing 0.1% (v/v) Triton X-100, 1% (w/v) BSA, and 10% (v/v) donkey serum
prior to incubation with Alexa Fluor 594-conjugated donkey anti-rabbit IgG (Life
Technologies A21207, 1 in 200 dilution) for 1 h at RT. Finally, the cells were
washed with PBS, mounted in ProLong® Gold anti-fade reagent containing nuclear
stain 4’,6-diamidino-2-phenylindole (DAPI), and visualised using a LSM510 laser
scanning confocal imaging system (Carl Zeiss). Images were analysed by Meta-
morph software to generate Pearson’s correlation coefﬁcients.
For experiments involving co-expression of SOCS3-GFP and cavin-1-mCherry
in cavin-1−/− MEFs, cells at 80–90% conﬂuence on 6 cm dishes were transfected
with 1 µg of each construct using PolyFect transfection reagent as per the
manufacturer’s instructions. The following day, cells were seeded into ×16 Lab-Tek
chamber slides (Fisher Scientiﬁc) at a density of 5 × 104 cells per chamber and
cultured for a further 24 h. Cells were then washed twice with Hanks' balanced salt
solution with Ca2+/Mg2+ and 0.2% (w/v) sucrose to preserve morphology before
ﬁxing by incubation with 4% (w/v) PFA at RT for 20 min in the dark. After
removal of ﬁxative and two washes with PBS, nuclei were stained with 10 µg ml−1
Hoechst 33342 (Life Technologies) prior to imaging using a VivaTome spinning
disk confocal microscope (Carl Zeiss). Images were analysed using Fiji ImageJ and
the Coloc 2 plugin.
Transmission electron microscopy. WT and SOCS3-null AS-M.5 cells were
seeded at a density of 1 × 106 cells per ml into 6-well plates and onto Thermanox
coverslips (13 mm diameter) for culturing to conﬂuency. The cells were then ﬁxed
in 1.5% (w/v) glutaraldehyde in 0.1 M sodium cacodylate buffer at 4 °C for 1 h.
Following three washes in 0.1 M sodium cacodylate buffer in 2% (w/v) sucrose, the
cells were incubated with 1% (w/v) osmium tetroxide/0.1 M sodium cacodylate for
1 h, washed three times in distilled water, and incubated in 0.5% (w/v) uranyl
acetate in the dark for 1 h. Following two rinses in distilled water, cells were
dehydrated in stepwise alcohol increments (30–100% (v/v)) and incubated over-
night in a 1:1 mix of propylene oxide/TAAB araldite Epon 812 resin. The pro-
pylene oxide was then allowed to evaporate to leave pure resin, which was changed
twice before the sample was embedded in fresh resin which was allowed to poly-
merise at 60 °C for 48 h. Ultrathin sections were cut using a Leica Ultracut UCT
and a Diatome diamond knife, contrast stained with aqueous 2% (w/v) methanolic
uranyl acetate and Reynolds lead citrate, and viewed using a LEO 912AB TEM
(Carl Zeiss) at an accelerating voltage of 120 kV. TIF images were captured using
an Olympus Soft Imaging System and image contrast modiﬁed using Adobe
Photoshop CS.
Statistics. Statistical signiﬁcance was assessed either by one-way analysis of var-
iance or unpaired t-tests with an α probability of 0.05. At least three separate
experiments were used for analysis.
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